The health department in Jaipur has taken decisive action by declaring ten products, comprising seven pharmaceutical drugs and three cosmetic items, as not meeting standard quality requirements. This declaration follows rigorous testing conducted between January 16 and 31, 2024, as part of ongoing quality surveillance efforts.
Immediate Withdrawal and Regulatory Action Ordered
An official from the department confirmed that detailed information regarding these substandard products has been promptly shared with drug control officers across all districts in the region. The primary directive is to ensure the immediate withdrawal of existing stocks from the market to protect public health and safety.
Strict Measures to Prevent Further Sale
Authorities have issued clear directions to halt any further sale or use of these flagged items. Additionally, action will be pursued under the provisions of the Drugs and Cosmetics Act, 1940, which governs the regulation of drugs and cosmetics in India, ensuring compliance and accountability.
List of Manufacturers with Failed Products
The drugs and cosmetic products that failed the quality tests originate from various manufacturers across multiple states. The companies involved include:
- BON-HEUR Pharmaceuticals based in Haridwar, Uttarakhand
- Titans Pharma located in Una, Himachal Pradesh
- Primus Pharmaceuticals operating from Sirmour, Himachal Pradesh
- Moon Marks Pharmaceuticals situated in Kangra, Himachal Pradesh
- Healthy Life Pharma Pvt Ltd from Palghar, Maharashtra
- Neubin Life Sciences Pvt Ltd based in Roorkee, Uttarakhand
- Innova Captab Ltd located in Baddi, Himachal Pradesh
- Pushp Henna Pvt Ltd from Sojat City, Rajasthan
- Veinik India Limited based in Beawar, Rajasthan
- Sankhla Mehandi Udhyog operating from Sojat City in Pali, Rajasthan
This crackdown highlights the health department's commitment to enforcing quality standards and safeguarding consumers from potentially harmful or ineffective products. The move is part of broader initiatives to enhance regulatory oversight in the pharmaceutical and cosmetic sectors.
